Policlinico Gemelli
↗Rome, Italy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS is one of Europe's largest private non-profit academic medical centers and the leading oncology hospital in Italy. Established as a foundation in 2015 to manage the university hospital of the Università Cattolica del Sacro Cuore, it was recognized by the Italian Ministry of Health as an IRCCS (Scientific Institute for Research, Hospitalization and Health Care) specializing in Personalized Medicine and Innovative Biotechnologies.
The institution serves as a critical hub for global pharmaceutical clinical trials, operating a dedicated Clinical Trial Center (CTC) that manages hundreds of profit and non-profit studies annually. It integrates high-complexity clinical care with translational research, supported by advanced facilities such as the Gemelli Science and Technology Park (G-STeP) and the 'Gemelli Generator' AI data science platform. It is consistently ranked as the best hospital in Italy and among the top 40 globally by Newsweek.
CLASSIFICATION
Company Type:CRO
Industry:Healthcare Services
Sub-Industry:Academic Medical Center & IRCCS (Research Hospital)
SIZE & FINANCIALS
Employees:5001-10000
Revenue:$500M-$1B
Founded:1964
Ownership:nonprofit
Status:operating
FUNDING
Investors:Università Cattolica del Sacro Cuore, Istituto Giuseppe Toniolo di Studi Superiori
PIPELINE
Stage:Commercial
Lead Drug Stage:Phase 4 (Trial Site/Investigator)
Modalities:Small molecule, mAb, Cell therapy, Gene therapy, Digital Therapeutics, Radiomics, Liquid Biopsy
Active Trials:710
Trial Phases:Phase 1: 45 | Phase 2: 150 | Phase 3: 210 | Phase 4: 80
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Università Cattolica del Sacro Cuore
Subsidiaries:Clinical Trial Center (CTC) S.p.A., Gemelli Isola S.p.A. Società Benefit, Gemelli Digital Medicine & Health (GDMH) S.r.l., XBIOGem S.r.l.
Key Partnerships:Guardant Health (Liquid biopsy testing service), Palantir Technologies (AI/Foundry data science platform), GE HealthCare (Strategic oncology and cardiology collaboration), Deenova (Pharmacy automation and traceability), Microsoft (Cloud and AI infrastructure for GDMH)
COMPETITION
Position:Leader
Competitors:Ospedale San Raffaele (Milan), Istituto Europeo di Oncologia (IEO), Humanitas Research Hospital (Milan), Ospedale Pediatrico Bambino Gesù
LEADERSHIP
Key Executives:
Daniele Franco - Chairman
Daniele Piacentini - General Manager
Antonio Gasbarrini - Scientific Director
Scientific Founders:Agostino Gemelli
Board Members:Elena Beccalli, Giuseppe Fioroni, Massimo Antonelli, Guido Carpani, Giuseppe Fontana
LINKS
Website:policlinicogemelli.it
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Policlinico Gemelli. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.